Effect of Neem (Azadirchta indica) on serum glycoprotein contents of rats administered 1,2 dimethylhydrazine

Toxicology Mechanisms and Methods

Volumn 19, Issue 4, 2009, Pages 298-301

  Ramzanighara, Abdollah ^a   Ezzatighadi, Fereshteh ^a   Rai, D V ^a   Dhawan, Davinder K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Azadirchta indica; Colorectal cancer; Dimethylhydrizine (DMH); Lipid bound sialic acid; Total sialic acid

Indexed keywords

AZADIRACHTA INDICA EXTRACT; DIMETHYLHYDRAZINE; GLYCOPROTEIN; SIALIC ACID;

ANIMAL EXPERIMENT; ARTICLE; AZADIRACHTA INDICA; BLOOD SAMPLING; CANCER INCIDENCE; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUPPLEMENTATION; VEIN PUNCTURE;

1,2-DIMETHYLHYDRAZINE; ANIMALS; AZADIRACHTA; BODY WEIGHT; CARCINOGENS; COLONIC NEOPLASMS; GLYCERIDES; GLYCOPROTEINS; MALE; N-ACETYLNEURAMINIC ACID; PLANT EXTRACTS; PLANT LEAVES; PLANT OILS; RATS; RATS, WISTAR; TERPENES;

ANIMALIA; AZADIRACHTA INDICA; RATTUS;

EID: 70350496381     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510802646523     Document Type: Article

References (32)

1. Akamatsu S, Yazawa S, Tachikawa T. 1996. a-2-3 Sialyltransferase associated with synthesis of CA 19-9 in colorectal tumors. Cancer 77:7-9.
2. Balasenthil S, Arivazhagan S, Ramachandran CR, Ramachandran V, Nagini S. 1999. Chemopreventive potential of neem (Azadirachta indica) on 7,12-dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinogenesis. J Ethnopharmacol 67:189-195.
3. Berdowska I. 2004. Cysteine proteases as disease markers. Clin Chem Acta 342:41-69.
4. Burger MM, Goldberg A. 1967. Identifcation of a tumor-specifc determinant on neoplastic cell surfaces. Proc Natl Acad Sci USA 57:359-366.
5. Cannell DW, Sadeeva N, Mathur H, Nguyen NV. 2001. Te use of plant extract in a cosmetic composition to protect keratinous fbers. Available online at: http://ww.wipo.int/ Accessed 6 February 2008.
6. Cumar FA, Brady RO, Kolodny EH, McFarland VW, Mora PT. 1970. Enzymatic block in the synthesis of gangliosides in DNA virus-transformed tumorigenic mouse cell lines. Proc Natl Acad Sci USA 67:757-764.
7. Dani V, Goel A, Vaiphei K, Dhawan DK. 2007. Chemopreventive potential of zinc in experimentally induced colon carcinogenesis. Toxicol Lett 171:10-18.
8. Davidsohn I, Kovarik S, Lee CL. 1966. A, B, and 0 substances in gastrointestinal carcinoma. Arch Pathol 81:381-390.
9. De Albuquerque Garcia Redondo P, Nakamura CV, de Souza W, Morgado-Díaz JA. 2004. Diferential expression of sialic acid and N-acetylgalactosamine residues on the cell surface of intestinal epithelial cells according to normal or metastatic potential. J Histochem Cytochem 52:629-640.
10. Dudeja PK, Brasitus TA. 1990. 2-Dimethylhydrazine-induced alterations in lipid peroxidation in preneoplastic and neoplastic colonic tissues. Biochim Biophys Acta 1046:267-270.
11. Fishman PH, Brady RO, Bradley RM, Aronson SA, Todaro GJ. 1974. Absence of a specifc ganglioside galactosyltransferase in mouse cells transformed by murine sarcoma virus. Proc Natl Acad Sci USA 71:298-301.
12. Gold P, Gold M, Freedman S. 1968. Cellular location of carcino embryonic antigens of the human digestive system. Cancer Res 28:1331-1334.
13. Goodarzi MT, Shafei M, Nomani H, Shahriarahmadi A. 2005. Relationship between total and lipid-bound serum sialic acid and some tumor markers. Iran J Med Sci 30:124-127.
14. Hakomori S. 1970. Cell density-dependent changes of glycolipid concentrations in fbroblasts and loss of this response in virus-transformed cells. Proc Natl Acad Sci USA 67:1741-1747.
15. Katopodis N, Hirshaut Y, Geller NL. 1982. Lipid-associated serum sialic acid test for the detection of human cancer. Cancer Res 42:5270-5275.
16. Katopodis N, Stock CC. 1980. Improved method to determine lipidbound sialic acid in plasma serum. Res Commun Chem Path Pharmacol 30:171-180.
17. LaMont JT, O'Gorman TA. 1978. Experimental colon cancer. Gastroenterology 75:1157-1169.
18. Laterz O F, Price CP, Scott MG. 2002. Cystatin C an improved estimator of glomerular fltration rate. Clin Chem 48:699-707.
19. Lewis CL, Brenner AT, Grifth JM, Pignone MP. 2008. Te uptake and effect of a mailed multi-modal colon cancer screening intervention: a pilot controlled trial. Implement Sci 3:32.
20. Li CJ, Wang C, Pardee AB. 1995. Induction of apoptosis by beta-lapachone in human prostate cancer cells. Cancer Res 55:3712-3715.
21. Lopez Saez JJ, Senra-Varela A. 1995. Evaluation of lipid-bound sialic acid (LASA) as a tumor marker. Int J Biol Markers 10:174-179.
22. Mandal-Ghosh I, Chattopadhyay U, Baral R. 2007. Neem leaf preparation enhances T1 type immune response and anti-tumor immunity against breast tumor associated antigen. Cancer Immun 30:7-8.
23. Miyazaki K, Ohmori K, Izawa M. 2004. Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers. Cancer Res 64:4498-4505.
24. Mora P T, Fishman PH, Bussin RH, Brady RO, McFarland VW. 1973. Transformation of Swiss 3T3 cells by murine sarcoma virus is followed by decrease in a glycolipid glycosyl transferase. Nature New Biol 245:226-229.
25. Painbeni T, Gamelin E, Cailleux A. 1997. Plasma sialic acid as a marker of the efect of the treatment on metastatic colorectal cancer. Eur J Cancer 33:2216-2220.
26. Pokorny RM, Hunt L, Galandiuk S. 2000. What's new with tumor markers for colorectal cancer? Dig Surg 17:209-215.
27. Romppanen J, Petaja J, Heikinheimo M. 1998. Total and lipid-bound serum sialic acid in children with malignancy or infections. Anticancer Res 18:2793-2797.
28. Sameni M, Moin K, Sloane BF. 2000. Imaging proteolysis by living human breast cancer cells. Neoplasia 2:496-504.
29. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM. 1999. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20:1425-1431.
30. Stellner K, Hakomori S. 1973. Enzymatic conversion of H1-glycolipid to A- or B-glycolipid and defciency of these enzyme activities in adenocarcinoma. Biochem Biophys Res Commun 55:439-445.
31. Waters PJ, Lewry E, Pennock CA. 1992. Measurement of sialic acid in serum and urine: clinical applications and limitations. Ann Clin Biochem 29:625-637.
32. Weisburger JH. 1971. Colon carcinogens: their metabolism and mode of action. Cancer 28:60-70.